Preferred Label : Zinbryta;
Origin ID : M000622365;
Related record
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2018/66214a-fra.php
2018
false
false
false
Canada
French
English
pharmacovigilance note
Safety-Based drug withdrawals
risk
encephalitis
daclizumab
meningoencephalitis
meningoencephalitis
encephalitis
multiple sclerosis
guidelines for drug use
popular works
Chemical and Drug Induced Liver Injury
Zinbryta
Daclizumab
---
